AstraZeneca Pharma India Limited (NSE:ASTRAZEN)

AstraZeneca Pharma India Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	204,584	133,010	81,183	63,886	75,255	59,789
Market Cap Growth	32.43%	63.84%	27.07%	-15.11%	25.87%	19.68%
Enterprise Value	199,787	127,861	76,552	60,484	72,857	57,477
Last Close Price	8189.50	5310.51	3228.09	2525.57	2976.40	2376.15
PE Ratio	210.98	82.35	81.76	103.71	80.66	82.80
PS Ratio	12.64	10.27	8.09	7.93	9.25	7.19
PB Ratio	30.11	18.68	13.79	12.49	16.50	16.41
P/TBV Ratio	30.20	18.74	13.79	12.49	16.50	16.41
P/FCF Ratio	-	777.38	163.12	70.07	77.53	81.68
P/OCF Ratio	-	477.25	139.27	63.38	71.82	68.39
EV/Sales Ratio	12.34	9.87	7.63	7.51	8.96	6.91
EV/EBITDA Ratio	96.47	69.81	47.45	73.16	54.94	48.72
EV/EBIT Ratio	103.60	74.58	51.43	87.20	62.67	56.04
EV/FCF Ratio	-	747.29	153.81	66.33	75.06	78.52
Debt / Equity Ratio	0.03	0.01	0.01	0.02	0.03	0.03
Debt / EBITDA Ratio	0.08	0.02	0.04	0.10	0.09	0.10
Debt / FCF Ratio	-	0.27	0.14	0.10	0.13	0.16
Asset Turnover	-	1.26	1.09	0.99	1.10	1.31
Inventory Turnover	-	2.87	2.22	2.11	1.85	2.20
Quick Ratio	-	1.89	1.61	1.64	1.46	1.06
Current Ratio	-	2.61	2.18	2.12	2.04	1.66
Return on Equity (ROE)	-	24.84%	18.05%	12.73%	22.74%	21.71%
Return on Assets (ROA)	-	10.39%	10.11%	5.32%	9.81%	10.11%
Return on Capital (ROIC)	17.77%	16.33%	16.67%	8.77%	17.21%	18.93%
Return on Capital Employed (ROCE)	-	23.80%	24.80%	13.20%	24.70%	27.10%
Earnings Yield	0.47%	1.21%	1.22%	0.96%	1.24%	1.21%
FCF Yield	-	0.13%	0.61%	1.43%	1.29%	1.22%
Dividend Yield	0.30%	0.45%	0.50%	0.40%	0.07%	0.04%
Payout Ratio	-	24.77%	20.14%	8.12%	5.36%	3.46%
Total Shareholder Return	0.29%	0.45%	0.50%	0.40%	0.07%	0.04%

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.